Large-conductance Ca2+-activated K+ channel beta1-subunit knockout mice are not hypertensive

Am J Physiol Heart Circ Physiol. 2011 Feb;300(2):H476-85. doi: 10.1152/ajpheart.00975.2010. Epub 2010 Dec 3.

Abstract

Large-conductance Ca2+-activated K+ (BK) channels are composed of pore-forming α-subunits and accessory β1-subunits that modulate Ca2+ sensitivity. BK channels regulate arterial myogenic tone and renal Na+ clearance/K+ reabsorption. Previous studies using indirect or short-term blood pressure measurements found that BK channel β1-subunit knockout (BK β1-KO) mice were hypertensive. We evaluated 24-h mean arterial pressure (MAP) and heart rate in BK β1-KO mice using radiotelemetry. BK β1-KO mice did not have a higher 24-h average MAP when compared with wild-type (WT) mice, although MAP was ∼10 mmHg higher at night. The dose-dependent peak declines in MAP by nifedipine were only slightly larger in BK β1-KO mice. In BK β1-KO mice, giving 1% NaCl to mice to drink for 7 days caused a transient (5 days) elevation of MAP (∼5 mmHg); MAP returned to pre-saline levels by day 6. BK β1-KO mesenteric arteries in vitro demonstrated diminished contractile responses to paxilline, increased reactivity to Bay K 8644 and norepinephrine (NE), and maintained relaxation to isoproterenol. Paxilline and Bay K 8644 did not constrict WT or BK β1-KO mesenteric veins (MV). BK β1-subunits are not expressed in MV. The results indicate that BK β1-KO mice are not hypertensive on normal or high-salt intake. BK channel deficiency increases arterial reactivity to NE and L-type Ca2+ channel function in vitro, but the L-type Ca2+ channel modulation of MAP is not altered in BK β1-KO mice. BK and L-type Ca(2+) channels do not modulate murine venous tone. It appears that selective loss of BK channel function in arteries only is not sufficient to cause sustained hypertension.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Blood Pressure / genetics
  • Blood Pressure / physiology
  • Body Weight / physiology
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / drug effects
  • Calcium Channels, L-Type / genetics
  • Calcium Channels, L-Type / physiology
  • Heart / anatomy & histology
  • Heart Rate / drug effects
  • Heart Rate / genetics
  • Heart Rate / physiology
  • Hypertension / genetics*
  • Hypertension / physiopathology
  • Lac Operon / genetics
  • Large-Conductance Calcium-Activated Potassium Channel beta Subunits / drug effects
  • Large-Conductance Calcium-Activated Potassium Channel beta Subunits / genetics*
  • Large-Conductance Calcium-Activated Potassium Channel beta Subunits / physiology*
  • Mesenteric Arteries / metabolism
  • Mesenteric Arteries / physiology
  • Mesenteric Veins / drug effects
  • Mesenteric Veins / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Muscle Contraction / genetics
  • Muscle Contraction / physiology
  • Muscle Relaxation / genetics
  • Muscle Relaxation / physiology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology
  • Nifedipine / pharmacology
  • Organ Size / physiology
  • Potassium Channel Blockers / pharmacology
  • Vasodilation / genetics
  • Vasodilation / physiology

Substances

  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Kcnmb1 protein, mouse
  • Large-Conductance Calcium-Activated Potassium Channel beta Subunits
  • Potassium Channel Blockers
  • Nifedipine